Sensorion (FR0012596468 ? ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent loss disorders, today announces ...
Healthbeat on MSN
When conspiracy theories dictate global vaccine policy
Gavi, the global organization that finances and distributes vaccines in poorer countries, finds itself in a funding standoff ...
18hon MSN
‘Oni Hunter X' Lands at enGEN3 in Partnership With Oni Force, GK Labs Investment (EXCLUSIVE)
enGEN3, a participatory storytelling platform, has formed a strategic partnership with Web3 anime brand Oni Force to develop ...
A team of biochemists at the University of California, Santa Cruz, has developed a faster way to identify molecules in the ...
News Medical on MSN
SynGenSys introduces Liver.SET synthetic promoter library for liver-specific gene expression for in vivo gene therapies
SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced ...
In 1869, Swiss scientist Friedrich Miescher isolated a mysterious substance from cell nuclei—an overlooked finding that would ...
Studying the shape of tissues and organs is critical to understanding how they are formed. Embryonic development happens in ...
Broadly neutralizing antibodies, or bnAbs, are a long‑standing goal of HIV vaccine research because they can disable many strains of the virus at once.
The new workflow was adapted from an enzymatic DNA tagging technology, DNA-TAG, previously developed in the Devaraj lab. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results